CCL21-Gene Modified Dendritic Cell Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CCL21-Gene Modified Dendritic Cell Vaccine, covering 2025-01-14 to 2025-01-14. Get the full timeline:
Most recent: Clinical Trial Update: CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer [Phase 1]